In vitro Dermal Absorption of Hydroquinone: Protocol Validation and Applicability on Illegal Skin-Whitening Cosmetics
Authors:
- Gamze AtesGAGamze Ates
- Patricia CoursellePCPatricia Courselle
- Jacques O. De BeerJBJacques O. De Beer
- Vera RogiersVRVera Rogiers
- Benoit HendrickxBHBenoit Hendrickx
- Eric DeconinckEDEric Deconinck
- Kristien De PaepeKPKristien De Paepe
- 1 January 2016
- journal article
- research article
- Published by S. Karger AG in Skin Pharmacology and Physiology
- Vol. 29 (6) , 300-308
Abstract
In Europe, hydroquinone is a forbidden cosmetic ingredient. It is, however, still abundantly used because of its effective skin-whitening properties. The question arises as to whether the quantities of hydroquinone used become systemically available and may cause damage to human health. Dermal absorption studies can provide this information. In the EU, dermal absorption has to be assessed in vitro since the Cosmetic Regulation 1223/2009/EC forbids the use of animals. To obtain human-relevant data, a Franz diffusion cell protocol was validated using human skin. The results obtained were comparable to those from a multicentre validation study. The protocol was applied to hydroquinone and the dermal absorption ranged between 31 and 44%, which is within the range of published in vivo human values. This shows that a well-validated in vitro dermal absorption study using human skin provides relevant human data. The validated protocol was used to determine the dermal absorption of illegal skin-whitening cosmetics containing hydroquinone. All samples gave high dermal absorption values, rendering them all unsafe for human health. These results add to our knowledge of illegal cosmetics on the EU market, namely that they exhibit a negative toxicological profile and are likely to induce health problems.Keywords
This publication has 22 references indexed in Scilit:
- Illegal cosmetics on the EU market: a threat for human health?Archives of Toxicology, 2014
- Characterization of suspected illegal skin whitening cosmeticsJournal of Pharmaceutical and Biomedical Analysis, 2014
- Widespread Use of Toxic Skin Lightening Compounds: Medical and Psychosocial AspectsDermatologic Clinics, 2011
- The safety of hydroquinone: A dermatologist's response to the 2006 Federal RegisterJournal of the American Academy of Dermatology, 2007
- The treatment of melasma: A review of clinical trialsJournal of the American Academy of Dermatology, 2006
- The safety of hydroquinoneJournal of the European Academy of Dermatology and Venereology, 2006
- Survey and mechanism of skin depigmenting and lightening agentsPhytotherapy Research, 2006
- Toxicology and health risks of hydroquinone in skin lightening formulationsJournal of the European Academy of Dermatology and Venereology, 2005
- A clinical, prospective, randomized, double‐blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasmaInternational Journal of Dermatology, 2003
- Inhibition of Melanin Formation by Chemical AgentsJournal of Investigative Dermatology, 1952